v1
Docetaxel and exisulind in hormone-refractory prostate cancer.
- NobleID
- NI5P14W96R31S32
- Persistent link
- https://nobleid.org/ark:/48914/w1/20260515/02FFC989
Type:Journal Article
0 views
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims